CM Life Sciences III Inc. Intellectual Property Contracts & Agreements

2 Contracts & Agreements

Browse by Subcategory

License Agreements (2 contracts)

Recent Contracts

First Amendment to Exclusive License Agreement by and between EQRx, Inc. and Lynk Pharmaceutical (Hangzhou) Co., Ltd dated September 9, 2022 (Filed With SEC on November 10, 2022)
First Amendment to Exclusive License Agreement by and between EQRx, Inc. and CStone Pharmaceuticals, dated August 15, 2022 (Filed With SEC on November 10, 2022)